-
SonixTOUCH
- Emergency Medicine
- Reproductive Medicine
- Anesthesiology
- Breast
- Endocrinology
- Pharma Studies
Sonix OP/SP/MDP
-
OpenSONIX Platform
- Overview
- SonixTOUCH Research
- SonixDAQ
- SonixGPS
- Elastography
Academic Research
-
Support and Registration
- Support Plans
- Warranty Registration
- Software Update Registration
- Contacting Support
-
- Directors
- Management Team
- Quality Statement
- Press Releases
- Careers
- Upcoming Events
- Awards
- Media
- Contact Us
- Blog
Quality Statement
The Ultrasonix Medical Corporation Quality Management System is registered to the ISO 13485:2003 and has been approved in conformity with the requirements of Annex V, section 3.2 – Production quality assurance of Council Directive 93/42/EEC concerning medical devices and FDA 21 CFR Part 820 Quality System Regulation. The QMS provides a structure for excellence in product design and development, quality of manufactured goods, delivery times and elimination of non-value added costs.
Quality Policy
Ultrasonix Medical Corporation is dedicated to being a leader in the development of ultrasound systems to help Physicians and Clinicians deliver better patient care via:
- Innovation and scientific excellence
- The Development and Manufacturing of High Quality Ultrasound Systems
- Open and honest customer and supplier relationships
- Employee involvement and development
- Compliance with all relevant regulatory requirements
The management fulfils its commitment to quality also in such a way that all workers know, understand and carry out the quality policy.